COMMUNIQUÉS West-GlobeNewswire
-
AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
04/06/2026 -
Moleculin CEO, Walter Klemp, Highlights 45 Subject Enrollment Milestone in Recent Virtual Investor “What This Means” Segment
04/06/2026 -
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
04/06/2026 -
TOMI Environmental Solutions, Inc. Scales Food Safety Presence with SteraMist Hybrid Installation at Expanded Food Facility
04/06/2026 -
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
04/06/2026 -
SS Innovations Announces Completion of World’s Longest-Distance Robotic Telesurgery
04/06/2026 -
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18
04/06/2026 -
RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd
04/06/2026 -
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
04/06/2026 -
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
04/06/2026 -
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
04/06/2026 -
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
04/06/2026 -
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
04/06/2026 -
Noom Members Kept Losing Weight a Full Year After the Program Ended, Largest-Ever Noom Randomized Clinical Trial Shows
04/06/2026 -
Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026
04/06/2026 -
Daré Bioscience Announces the Upcoming Launch of Flora Sync LF5™ Vaginal Probiotic Capsules
04/06/2026 -
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
04/06/2026 -
Melanoma Research Alliance Appoints Stephanie Kauffman as Chief Executive Officer
04/06/2026 -
Pure Harvest Corporate Group (OTC: PHCG), Operating as Mixie Technologies, Announces HoloTwin 2.0 Framework for Large-Scale 3D Visualization in the Browser
04/06/2026
Pages